Augmented uptake of 2-C-14-D-deoxyglucose in reversibly-injured myocardium
Creators
- 1. Massachusetts Univ., Worcester (USA). Div. of Cardiovascular Medicine
- 2. Massachusetts Univ., Worcester (USA). Dept. of Nuclear Medicine
Description
We studied the cardiac uptake of 2-14C-D-deoxyglucose (14C-DG) in 6 dogs subjected to a 15 min left anterior descending coronary artery (LAD) occlusion followed by 30 min reflow. Coronary arterial flows during occlusion were determined with 46Sc microspheres. After 30 min reflow, 50 mCi 14C-DG were given intravenously to determine cardiac uptake. The animal was killed 45 min later and 46Sc counts/min were determined in gamma and beta counters. Quenching was determined with non radioactive blood for both isotopes in the beta counter. Contribution of 46Sc counts/min to the 14C channel was subtracted, 14C uptake was in DPM/g and was higher in the cardiac ischemic regions of four of the six dogs. In three of the six animals there was an inverse curvilinear relation between 14C-DG cardiac uptake and occlusion flow. This observation was further confirmed by high resolution autoradiography, indicating that enhanced cardiac uptake of radiolabeled DG may be a useful positron emission tomographic marker for reversible myocardial ischemia. (orig.)
Additional details
Publishing Information
- Journal Title
- Eur. J. Nucl. Med.
- Journal Volume
- 13
- Journal Issue
- 11
- Series
- Eur. J. Nucl. Med.
- Journal Page Range
- 557-562
- ISSN
- 0340-6997
- CODEN
- EJNMD
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 19027205
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
- Descriptors DEI
- BLOOD FLOW; CARBON 14; CORONARIES; DOGS; GLUCOSE; INTRAVENOUS INJECTION; ISCHEMIA; METABOLISM; MICROSPHERES; MYOCARDIUM; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SCANDIUM 46; SURGERY; TRACER TECHNIQUES; UPTAKE
- Descriptors DEC
- ALDEHYDES; ANEMIAS; ANIMALS; ARTERIES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BLOOD VESSELS; BODY; CARBOHYDRATES; CARBON ISOTOPES; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; COMPUTERIZED TOMOGRAPHY; DAYS LIVING RADIOISOTOPES; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; EVEN-EVEN NUCLEI; HEART; HEMIC DISEASES; HEXOSES; INJECTION; INTAKE; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTO; ISOMERIC TRANSITION ISOTOPES; ISOTOPE APPLICATIONS; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MAMMALS; MATERIALS; MEDICINE; MONOSACCHARIDES; MUSCLES; NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; ORGANS; RADIOACTIVE MATERIALS; RADIOISOTOPES; SACCHARIDES; SCANDIUM ISOTOPES; SECONDS LIVING RADIOISOTOPES; SYMPTOMS; TOMOGRAPHY; VERTEBRATES; YEARS LIVING RADIOISOTOPES
Optional Information
- Contract/Grant/Project number
- Contract HL33514-01A1